title: Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemia.
authors.forename: Raphael
authors.initials: R
authors.lastname: Itzykson
authors.forename: Magali
authors.initials: M
authors.lastname: Le Garff-Tavernier
authors.forename: Sandrine
authors.initials: S
authors.lastname: Katsahian
authors.forename: Marie-Claude
authors.initials: MC
authors.lastname: Diemert
authors.forename: Lucile
authors.initials: L
authors.lastname: Musset
authors.forename: Veronique
authors.initials: V
authors.lastname: Leblond
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000686:Amyloidosis / Q000175:diagnosis; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D007147:Immunoglobulin Light Chains / Q000097:blood* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011379:Prognosis; D012189:Retrospective Studies; D013997:Time Factors; D008258:Waldenstrom Macroglobulinemia / Q000097:blood* / Q000628:therapy*
chemical_list: D007147:Immunoglobulin Light Chains